LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,235,471 | -29.8% | 3,885,753 | +47.5% | 0.00% | -33.3% |
| Q2 2023 | $6,032,256 | +10400341.4% | 2,634,173 | +10947.5% | 0.00% | – |
| Q1 2023 | $58 | -97.4% | 23,844 | -98.0% | 0.00% | -100.0% |
| Q4 2022 | $2,247 | -99.9% | 1,176,567 | +29.9% | 0.00% | 0.0% |
| Q3 2022 | $2,174,000 | +436.8% | 905,911 | +315.7% | 0.00% | – |
| Q2 2022 | $405,000 | -47.4% | 217,948 | -40.9% | 0.00% | – |
| Q1 2022 | $770,000 | -23.4% | 368,654 | +44.5% | 0.00% | -100.0% |
| Q4 2021 | $1,005,000 | +168.0% | 255,138 | +226.9% | 0.00% | – |
| Q3 2021 | $375,000 | -65.1% | 78,037 | -66.7% | 0.00% | -100.0% |
| Q2 2021 | $1,076,000 | -0.2% | 234,355 | +27.6% | 0.00% | 0.0% |
| Q1 2021 | $1,078,000 | -66.0% | 183,687 | -80.2% | 0.00% | -50.0% |
| Q4 2020 | $3,174,000 | +1606.5% | 928,173 | +620.0% | 0.00% | – |
| Q3 2020 | $186,000 | -96.6% | 128,918 | -90.2% | 0.00% | -100.0% |
| Q4 2019 | $5,435,000 | +47.9% | 1,309,722 | +7.3% | 0.01% | +16.7% |
| Q3 2019 | $3,674,000 | +1532.9% | 1,220,629 | +3308.6% | 0.01% | – |
| Q2 2019 | $225,000 | -7.0% | 35,810 | -17.9% | 0.00% | – |
| Q1 2019 | $242,000 | -61.7% | 43,608 | -54.2% | 0.00% | -100.0% |
| Q4 2018 | $632,000 | -74.6% | 95,169 | -59.2% | 0.00% | -66.7% |
| Q3 2018 | $2,490,000 | -67.0% | 233,307 | -62.9% | 0.00% | -70.0% |
| Q2 2018 | $7,552,000 | +100.5% | 629,353 | +65.1% | 0.01% | +100.0% |
| Q4 2017 | $3,767,000 | -20.2% | 381,266 | -0.7% | 0.01% | -28.6% |
| Q3 2017 | $4,718,000 | -58.6% | 383,871 | -44.6% | 0.01% | -65.0% |
| Q2 2017 | $11,397,000 | +329.9% | 692,835 | +274.8% | 0.02% | +300.0% |
| Q1 2017 | $2,651,000 | -15.5% | 184,845 | -18.5% | 0.01% | -28.6% |
| Q4 2016 | $3,137,000 | -62.3% | 226,852 | -50.7% | 0.01% | -50.0% |
| Q3 2016 | $8,311,000 | +29.5% | 459,950 | +2.9% | 0.01% | -6.7% |
| Q2 2016 | $6,417,000 | -50.2% | 447,199 | -58.6% | 0.02% | -53.1% |
| Q1 2016 | $12,896,000 | +13.9% | 1,079,140 | +26.9% | 0.03% | +33.3% |
| Q4 2015 | $11,319,000 | +230.0% | 850,407 | +166.3% | 0.02% | +242.9% |
| Q3 2015 | $3,430,000 | +405.9% | 319,381 | +279.1% | 0.01% | +600.0% |
| Q2 2015 | $678,000 | – | 84,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |